期刊文献+

鸡马立克氏病肾肿瘤p15基因的甲基化特异性PCR检测

Methylated specific PCR detection of p15 gene in kidney tumor of chicken with Marek's disease
原文传递
导出
摘要 选取300只1日龄公鸡,人工复制鸡马立克氏病(MD)模型,随机分为对照组和MD组,分别于35日龄、40日龄、45日龄采取鸡肾,观察病理组织学变化,通过甲基化特异性PCR方法,检测了MD病鸡肾肿瘤发生和发展过程中p15基因甲基化的变化,以探讨p15基因甲基化与肾肿瘤发生、发展的关系。结果显示,MD组鸡的临床表现以及肾组织的病理变化符合MD的特征,说明人工复制MD模型成功。在正常鸡肾组织中没有发生p15甲基化,在MD病鸡肾组织中p15甲基化的发生率高达61.7%,与正常对照组差异极显著(P<0.01),并呈时间效应。证实,p15基因甲基化与MD的发生、发展密切相关。 To investigate the relationship between the methylation of p15 gene and the genesis of kid-ney tumor in the development of Marek's disease(MD), 300 one-day-old chicks were randomly divided into control group and MD group. On 35,40 and 45 days-old, kidneys were collected and then pathologic changes were observed in the experimental replication MD cases and the variations of methylation of p15 gene in the genesis and development of kidney tumor of chicks with MD were detected by the methylated specific PCR. The results showed that the clinical manifestations and pathological changes of the kidney in the MD group were in accord with characteristics of MD,indicating that MD model was successfully generated. No methy-lation of p15 gene was generated in the control group,while 61.7% of methylation of p15 gene was found in the MD group, which was significantly higher(P〈0.01) than that in the control group in time-dependent manner. It was concluded that the methylation of p15 gene was intimately relevant to the genesis and development of MD.
出处 《中国兽医科学》 CAS CSCD 北大核心 2010年第1期61-64,共4页 Chinese Veterinary Science
基金 国家自然科学基金项目(30540053)
关键词 P15基因 甲基化 马立克氏病 甲基化特异性聚合酶链反应 p15 gene methylation kidney Marek's disease MS-PCR
  • 相关文献

参考文献9

二级参考文献44

  • 1周华蓉,沈建箴,付海英,叶宝国,范丽萍,林福安.巢式MSP法检测恶性血液病细胞株p16基因启动子甲基化状态的研究[J].中国实验血液学杂志,2006,14(2):375-378. 被引量:13
  • 2[1]WADA T,BERGGREN P,STEINECK G,et al.Bladder neoplams regions at chromosome 9 with putative tumor suppressor genes[J].Scand J Urol Nephrol,2003,37 (2):106-111.
  • 3[2]HERMAN J G,GRAFF J R,MYOHANEN S,et al.Methylation-specific PCR:A novel PCR assay for methylated status of CpG islands[J].Proc Natl Acad Sci USA,1996,93 (18):9821-9826.
  • 4[4]FURONAKA O,TAKESHIMA Y,AWAYA H,et al.Aberrant methylation of p14ARF,p15INK4b,p16INK4a genes and location of the primary site in pulmonary squamous cell carieinouma[J].Pathol Int,2004,54 (8):549-555.
  • 5[5]LI E,BEARD C,JAENISCH R.Role for DNA methylation in genomic imprinting[J].Nature,1993,366(6453):362-365.
  • 6[6]MONK M.Epigenetic programming of differential gene expression and evolution[J].Dev Genet,1995,17 (3):188-197.
  • 7[7]JONES P A,JONES P A,GONZALGO M L.Altered DNA methylation and genome instability:a new pathyway to cancer[J].Proc Natl Acad Sci USA,1997,94(6):2103-2105.
  • 8[8]DOMINGUEZ G,CARBALLIDO J,SILVA J,et al.p14ARF pro moter hyper met hylation in plasma DNA as an indicator of disease recurrence in bladder cancer patients[J].Clinical Cancer Res,2002,8(4):980-985.
  • 9[9]SANECHEZ R,CARBAULLODO J,CARCIA J M,et al.Prevalence of aberrant methylation of p14ARF over P16IN K4a in some human primary tumor[J].Mutat Res,2003,530(1-2):9-17.
  • 10[10]MARUYAMA R,TOYOOKA S,TOYOOKA K O,et al.Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features[J].Cancer Res,2001,61(24):8659-8663.

共引文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部